Austin, Texas, United States, August 28th, 2026, NewsDirect
- SS Innovation’s SSi Mantra system was used in more than 50 robotic surgeries in a single day at Mohak Bariatrics and Robotics in Indore, highlighting growing clinical utilization in India.
- The milestone comes as SS Innovations reports 224 SSi Mantra systems installed across 12 countries, providing a growing installed base for future procedure and instrument revenue.
- Second-quarter 2026 installations reached 30 systems, above the 25 systems modeled by the analyst cited in the supplied report.
- Quarterly revenue reached $13.9 million, up 39% year over year, while system sales increased 41% to $12.4 million.
- FDA review of the SSi Mantra 510(k) application is now expected by the end of the first quarter of 2027, while European CE marking remains targeted for the end of 2026.
- The company’s progress in India gives it a major commercial base while it pursues entry into the U.S. and European surgical robotics markets.
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is gaining another indication of the scale that its SSi Mantra surgical robotic system can support in India, where more than 50 robotic procedures were performed in a single day at Mohak Bariatrics and Robotics in Indore.
The milestone, announced by SS Innovations on LinkedIn, came on India’s 80th Independence Day and involved procedures conducted under the leadership of Dr. Mohit Bhandari. The event is notable less for the headline number than for what it demonstrates about the potential utilization of robotic surgery in a large healthcare market where adoption is still…
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII
Contact
IBN
www.InvestorBrandNetwork.com
[email protected]